Our target gene modification goal is to introduce three out of five amino acid (AA) changes within a 15 bp range (Supplementary Data Sequence 3) in the exon 10 region of the Psen1 gene in neuroblastoma cell line (N2A). This evidence concerns the gene PSEN1 and neuroblastoma.